ROTAHALER Device Optimization Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 5, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Asthma
Interventions
DRUG

Fluticasone Propionate / Salmeterol Xinafoate DISKUS

Fluticasone propionate and salmeterol xinafoate combination as a dry powder inhaler for oral inhalation with unit dose strength of 100/50 mcg (available in blister pack) administered via DISKUS (Ddpi) device.

DRUG

Fluticasone Propionate / Salmeterol Xinafoate ROTACAP

Fluticasone propionate and salmeterol xinafoate combination as a dry powder inhaler for oral inhalation with unit dose strength of 100/50 mcg (available in blister pack) administered via ROTAHALER (Rdpi) device.

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY